SynthesisBMC cancer2019

Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis.

Yawei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.